Skip to main content
. 2022 Jan 25;14(3):594. doi: 10.3390/cancers14030594

Table 1.

Newly discovered in the pathogenesis of PPGLs.

Gene Year of Discovery Pathophysiology Gene Type Metabolomics References
CSDE1 2016 Tumor suppressor gene involved in mRNA stability and cellular apoptosis Somatic Adrenergic [6,7]
H3F3A 2016 Encodes histone H3.3 protein that regulates chromatin formation Somatic NA [35,36]
MET 2016 MAPK signaling pathway Germline, somatic NA [23]
MERTK 2016 Tyrosine kinase receptor Germline NA [11,37,38]
UBTF-MAML3 2017 Unique methylation profile mRNA overexpression involved in Wnt receptor and hedgehog signaling pathways Fusion Adrenergic [6,39]
SLC25A11 2018 Encodes malate-oxalate carrier protein of malate-aspartate shuttle Germline Noradrenergic [40,41]
IRP1 2018 Cellular iron metabolism regulation Somatic noradrenergic [42]
DLST 2019 Encodes E2 subunit of mitochondrial α -KG complex which converts α-KG to succinyl-CoA Germline Noradrenergic [23,43]
SUCLG2 2021 Catalyzes conversion of succinyl-coA and ADP/GTP to succinate and ATP/GTP Germline Noradrenergic [44]